Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-110087
Filing Date
2025-11-13
Accepted
2025-11-13 16:57:16
Documents
5
Period of Report
2025-11-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0265587-6k_scinai.htm 6-K 13006
2 NOTICE AND PROXY STATEMENT OF ANNUAL GENERAL MEETING OF SHAREHOLDERS ea026558701ex99-1_scinai.htm EX-99.1 91380
3 PROXY CARD ea026558701ex99-2_scinai.htm EX-99.2 1462
4 GRAPHIC ex99-2_001.jpg GRAPHIC 320612
5 GRAPHIC ex99-2_002.jpg GRAPHIC 317591
  Complete submission text file 0001213900-25-110087.txt   986251
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 251479480
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)